Orasure Technologies (OSUR) Common Equity (2010 - 2025)
Orasure Technologies (OSUR) posted Common Equity of $340.8 million for Q4 2025, down 5.84% sequentially from $362.0 million in Q3 2025, and down 16.94% YoY from $410.3 million in Q4 2024.
Orasure Technologies (OSUR) Common Equity (2010 - 2025) Analysis & Trends
Orasure Technologies has reported Common Equity for 16 years, with the latest figure at $340.8 million in Q4 2025.
- Quarterly Common Equity fell 16.94% year-over-year to $340.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $340.8 million (down 16.94% YoY) and the FY2025 annual result came in at $340.8 million, down 16.94% from the prior year.
- Common Equity eased to $340.8 million in Q4 2025 per OSUR's latest filing, from $362.0 million in the prior quarter.
- Over five years, Common Equity peaked at $430.7 million in Q4 2023 and troughed at $340.8 million in Q4 2025.
- A 5-year average of $389.2 million and a median of $394.2 million in 2023 frame the typical range for Common Equity.
- The sharpest annual moves came in 2021 and 2025: Common Equity soared 39.08% in 2021, then slipped 16.94% in 2025.
- Over 5 years, Common Equity stood at $380.5 million in 2021, then fell by 4.23% to $364.4 million in 2022, then climbed by 18.18% to $430.7 million in 2023, then dropped by 4.72% to $410.3 million in 2024, then retreated by 16.94% to $340.8 million in 2025.
- According to Business Quant data, Common Equity over the past three periods registered $340.8 million, $362.0 million, and $380.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 18.30 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 24.42 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 21.60 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 6.59 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 19.08 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 2.99 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 4.80 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 8.24 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 6.21 Bn |
| 10 | Orasure Technologies | 274.50 Mn | 75.22 Mn | - | 340.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 340.83 Mn |
| Sep 30, 2025 | 361.98 Mn |
| Jun 30, 2025 | 380.72 Mn |
| Mar 31, 2025 | 396.28 Mn |
| Dec 31, 2024 | 410.34 Mn |
| Sep 30, 2024 | 425.57 Mn |
| Jun 30, 2024 | 425.84 Mn |
| Mar 31, 2024 | 426.25 Mn |
| Dec 31, 2023 | 430.67 Mn |
| Sep 30, 2023 | 404.89 Mn |
| Jun 30, 2023 | 394.14 Mn |
| Mar 31, 2023 | 394.18 Mn |
| Dec 31, 2022 | 364.43 Mn |
| Sep 30, 2022 | 342.45 Mn |
| Jun 30, 2022 | 344.43 Mn |
| Mar 31, 2022 | 364.91 Mn |
| Dec 31, 2021 | 380.53 Mn |
| Sep 30, 2021 | 387.82 Mn |
| Jun 30, 2021 | 404.82 Mn |
| Mar 31, 2021 | 403.54 Mn |